Home › Research › Mild cognitive impairment
The characterisation of subjective cognitive decline
Frank Jessen, Rebecca England Amariglio, Rachel F. Buckley, Wiesje M. van der Flier, Ying Han, José Luís Molinuevo, Laura A. Rabin, Dorene M. Rentz, Octavio Rodríguez‐Gómez, Andrew J. Saykin, Sietske A.M. Sikkes, Colette M. Smart, Steffen Wolfsgruber, Michael Wagner. The Lancet Neurology, 2020-01-17
Topic: Risk, prevention and care in population studies
This text discusses the characterisation of subjective cognitive decline (SCD), a term conceived in 2014 to describe cognitively unimpaired individuals who are concerned about reduced cognitive function and seek medical help. Epidemiological data show that individuals with SCD have an increased risk for mild cognitive impairment and dementia. However, the majority of individuals with SCD will not show progressive cognitive decline.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Jessen, F., Amariglio, R. E., Buckley, R. F., van der Flier, W. M., Han, Y., Molinuevo, J. L., et al. (2020). The characterisation of subjective cognitive decline. The Lancet Neurology. https://doi.org/10.1016/s1474-4422(19)30368-0
Vancouver
Jessen F, Amariglio RE, Buckley RF, van der Flier WM, Han Y, Molinuevo JL, et al. The characterisation of subjective cognitive decline. The Lancet Neurology. 2020. doi:10.1016/s1474-4422(19)30368-0. PMID: 31958406.
BibTeX
@article{jessen2020-31958406,
author = {Jessen, Frank and Amariglio, Rebecca England and Buckley, Rachel F. and van der Flier, Wiesje M. and Han, Ying and Molinuevo, José Luís and Rabin, Laura A. and Rentz, Dorene M. and Rodríguez‐Gómez, Octavio and Saykin, Andrew J. and Sikkes, Sietske A.M. and Smart, Colette M. and Wolfsgruber, Steffen and Wagner, Michael},
title = {{The characterisation of subjective cognitive decline}},
journal = {The Lancet Neurology},
year = {2020},
doi = {10.1016/s1474-4422(19)30368-0},
pmid = {31958406},
url = {https://doi.org/10.1016/s1474-4422(19)30368-0}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 14 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- The term subjective cognitive decline (SCD) was conceived in 2014 to describe cognitively unimpaired individuals who are concerned that they have reduced cognitive function.
- Epidemiological data provide evidence that the risk for mild cognitive impairment and dementia is increased in individuals with SCD.
- The majority of individuals with SCD will not show progressive cognitive decline.
Why it matters
Discusses the characterisation of subjective cognitive decline.
How this study scored 62/100
Published in a leading specialty journal. Scored zero for study design, sample size, effect reported, studied in people and randomised / blinded because the record does not state it. We have no data on strength of evidence, so that was left out: it earned 59 of the 95 points we could judge it on, which is 62 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (The Lancet Neurology) |
| Journal's citation record | 3 / 4 | The Lancet Neurology: journal h-index 457 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | — / 5 | No evidence rating recorded — left out of this score |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 2 / 5 | 2020 — within 10 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomised / blinded | 0 / 2 | No randomisation or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 7 / 7 | Cited 1,383 times (OpenAlex, 2026-10-10) |
| Citations per year | 5 / 5 | 172.9 citations a year over 8 year(s) since 2020 |
| Impact for its field and year | 6 / 6 | Cited 103.8× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 4 / 4 | Cited 732 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Michael Wagner: h-index 93 (OpenAlex, whole career) |
| Institution's track record | 3 / 3 | Harvard University: institution h-index 3,235 (OpenAlex) |
| Multi-centre collaboration | 3 / 3 | OpenAlex lists 29 institution(s) in 7 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 31958406) |
| Free to read | 2 / 2 | Free to read |
| Points | 59 / 95 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 59 of the 95 points we could judge it on is 62 out of 100. |
| Total | 62 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1016/s1474-4422(19)30368-0
- PubMed: 31958406
- Original source →
- Free full text: The Lancet Neurology →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related studies in Mild cognitive impairment
Also tagged “examination”
840 studies in the library carry the topic tag “examination”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 840 tagged studies.